Please assess the completion status of the following clinical trial:

Trial Title: Identification of Gut Microbiome Biomarkers Associated to Acquisition of Enterobacteriae Highly Resistant to Third Generation Cephalosporines Following Ceftriaxone Treatment.

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18 years~* Able to comply with study requirement and to provide informed consent~* Outside the context of tutorship and / or guardianship, affiliated to the Social Security Regime and having consented to participate in the ARCMI study.~* Patient receiving ceftriaxone (1 gram or 2 grams per day) in the emergency department~Exclusion Criteria:~* Patients with acute anorectal pathology incompatible with the swabbing strategy or digital rectal examination.~* Prescription of another dosage of ceftriaxone (more than 2 grams per day)~* Patient with inflammatory bowel disease~* Allergy or contraindication to betalactamines and cephalosporins

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- patient under Ceftriaxone treatment (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).